Timothy Smith
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations (NCT03879460) | Timothy Smith | 2019-03-18 |
Track Timothy Smith automatically
Every clearance here is in the API, with alerts when new ones post.